HB 642Just filedInsurance & financial services
Limits prior authorization to once a year for neurodegenerative disease drugs
Filed by
Venton JonesDDemocrat· House District 100· Filed Nov 9, 2026The short version · AI summary
Health plans that cover prescription drugs could not require an enrollee to get more than one prior authorization (advance approval) per year for a drug prescribed to treat a neurodegenerative disease. This adds such diseases to the existing once-a-year limit for autoimmune diseases, hemophilia and Von Willebrand disease. A plan may still require new approval when an enrollee is prescribed a new drug for a neurodegenerative disease. It applies to plans delivered, issued or renewed on or after January 1, 2028. The act takes effect September 1, 2027.
What it means for you
If you or a family member takes a drug for a neurodegenerative disease, your plan could ask for approval of that drug only once a year. A new drug could still need new approval.
One email when it moves, at most one a day. Unsubscribe in one click from any email.